Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesBack to the home pageSearch  
Research Posters
 
Research Publications
Development Publications
Glossary of Terms

Home / Resources / Development Publications
 
Development Publications
 

2005  

Title:

Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.

Authors:

Mease PJ, Ginzler EM, Gluck OS, Schiff M, Goldman A, Greenwald M, Cohen S, Egan R, Quarles BJ, Schwartz KE.
Publication: J Rheumatol. 2005 Apr;32(4):616-21.
   
2004  

Title:

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus -- results of a multi center, randomized, double-blind, placebo-controlled trial.

Authors:

Petri MA, Mease PH, Merrill JT, Lahita RG, Iannini MJ, Yocum DE,  et al. 
Publication: Arthritis & Rheumatism 2004 Sept;50 (9):2858-68.
   
2002  

Title:

Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.

Authors:

Chang DM, Lan JL, Lin HY, Luo SF.
Publication: Arthritis & Rheumatism, 2002 Nov;46(11):2924-7
   

Title:

Autoimmunity, dehydroepiandrosterone (DHEA), and stress.

Authors:

Schwartz KE
Publication: J. Adolesc. Health, 2002;30(4 Suppl 1):37-43
   

Title:

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.

Authors:

van Vollenhoven RF
Publication: Expert Opin. Pharmacother., 2002;3(1):23-31
   

Title:

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus. A Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:

Petri MA, Lahita RG, van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE
Publication: Arthritis & Rheumatism, 2002;46:1820-29
   
2001  

Title:

Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women.

Authors:

Meno-Tetang GM, Blum RA, Schwartz KE, Jusko WJ
Publication: J. Clin. Pharmacol., 2001;41:1195-1205
   
2000  

Title:

Dehydroepiandrosterone in Systemic Lupus Erythematosus.

Authors:

van Vollenhoven RF
Publication: Rheum. Dis. Clin. North Am., 2000;26(2):349-62
   

Title:

Dehydroepiandrosterone in the treatment of systemic lupus erythematosus.

Authors:

van Vollenhoven RF
Publication: Rheumatology (Oxford), 2000;39(8):929-30
   
1999  

Title:

A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe Systemic Lupus Erythematosus.

Authors:

van Vollenhoven RF, Park JL, Genovese MC, West JC, McGuire JL
Publication: Lupus, 1999: 8(3):181-7
   
1998  

Title:

Quality control of dehydroepiandrosterone dietary supplement products.

Authors:

Parasrampuria J, Schwartz KE, Petesch R
Publication: JAMA, 1998: 280:1565
   

Title:

Dehydroepiandrosterone in Systemic Lupus Erythematosus: relationship between dosage, serum levels, and clinical response.

Authors:

Barry NN, McGuire JL, van Vollenhoven RF.
Publication: J. Rheumatology, 1198;25(12):2352-6
   

Title:

Treatment of Systemic Lupus Erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

Authors:

van Vollenhoven RF, Engleman EG, McGuire JL, Morabito LM
Publication: Rheumatology, 1998: 25:285-9
   
1996  

Title:

Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.

Authors:

van Vollenhoven RF, McGuire JL
Publication: Ann. Med. Interne., (Paris), 1996;147(4):290-6 Review
   
1995  

Title:

Dehydroepiandrosterone in Systemic Lupus Erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.

Authors:

van Vollenhoven RF, Engleman EG, McGuire JL
Publication: Arthritis & Rheumatism, 1995: 38(12):1826-1831
   
1994  

Title:

An open study of dehydroepiandrosterone in systemic lupus erythematosus products.

Authors:

van Vollenhoven RF, Engleman EG, McGuire JL
Publication: JAMA, 1994:37(9):1305-1310